Immunological response to intrathecal and systemic treatment with ganglioside antibody R-24 in patients with malignant melanoma

This publication has 14 references indexed in Scilit:

• Immunorecognition of different ganglioside epitopes on human normal and melanoma tissues
  International Journal of Cancer, 1992
• Immunorecognition of ganglioside epitopes: Correlation between affinity and cytotoxicity of ganglioside antibodies
  European Journal Of Cancer, 1992
• The eortc melanoma group exchange program: Evaluation of a multicenter monoclonal antibody study
  International Journal of Cancer, 1991
• Preliminary trial of specific targeting therapy against malignant glioma
  The Lancet, 1990
• REMISSION INDUCTION IN NON-HODGKIN LYMPHOMA WITH RESHAPED HUMAN MONOCLONAL ANTIBODY CAMPATH-1H
  The Lancet, 1988
• Monoclonal antibody R24 distinguishes between different N-acetyl- and N-glycolylneuraminic acid derivatives of ganglioside GD3
  Archives of Biochemistry and Biophysics, 1988
• Dissection of the lymphokine-activated killer phenomenon. Relative contribution of peripheral blood natural killer cells and T lymphocytes to cytolysis.
  The Journal of Experimental Medicine, 1986
• Inflammatory tumor response to monoclonal antibody infusion
  European Journal of Cancer and Clinical Oncology, 1985
• Distribution of the ganglioside GD3 in the human nervous system detected by R24 mouse monoclonal antibody
  Brain Research, 1984
• GD3, a prominent ganglioside of human melanoma. Detection and characterisation by mouse monoclonal antibody.
  The Journal of Experimental Medicine, 1982